LINDE PLC (LIN) Corporate Subsidiaries
LINDE PLC (LIN) is a publicly traded company on the Nasdaq, categorized under SIC 2810 (Industrial Inorganic Chemicals). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LIN
CIK: 1707925
Exchange: Nasdaq
SIC 2810: Industrial Inorganic Chemicals
Fiscal Year End: 12/31
State: L2
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMelissa Palmer
Audit LocationStamford, Connecticut, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-10-08 | 2026-10-01 | FORM 3 | 0001628280-26-065480 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001628280-26-065071 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001628280-26-065040 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | FORM 4 | 0001628280-26-057911 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0001628280-26-051289 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | FORM 8-K | 0001654954-26-007052 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-28 | 8-K | 0001193125-26-325127 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001083211-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001179998-26-000008 | View SEC Doc Filr Page |
| PX14A6G | 2026-06-25 | — | PX14A6G Filing | 0001214659-26-007718 | View SEC Doc Filr Page |
| 11-K | 2026-06-16 | 2025-12-31 | 11-K | 0001628280-26-043557 | View SEC Doc Filr Page |
| 11-K | 2026-06-16 | 2025-12-31 | 11-K | 0001628280-26-043550 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-08 | FORM 4 | 0002069183-26-000004 | View SEC Doc Filr Page |
| SD | 2026-05-28 | — | SD | 0001628280-26-038750 | View SEC Doc Filr Page |
| 3 | 2026-05-21 | 2026-05-15 | FORM 3 | 0001628280-26-037388 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-14 | FORM 4 | 0001628280-26-035907 | View SEC Doc Filr Page |
| 144 | 2026-05-15 | — | 144 Filing | 0001950047-26-004589 | View SEC Doc Filr Page |
| 144 | 2026-05-14 | — | 144 Filing | 0001959173-26-003606 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-221558 | View SEC Doc Filr Page |
| S-3ASR | 2026-05-05 | — | S-3ASR | 0001193125-26-206366 | View SEC Doc Filr Page |
| 10-Q | 2026-05-01 | 2026-03-31 | 10-Q | 0001628280-26-029165 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-05-01 | FORM 8-K | 0001654954-26-004202 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-30 | — | SCHEDULE 13G Filing | 0002100119-26-000687 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001193125-26-192284 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-07-28 | DEF 14A | 0001193125-26-192209 | View SEC Doc Filr Page |